Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain

Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database

(2013) Chris J Bushe et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

(2012) Renan P. Souza et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain

(2012) E.J. Brandl et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics

(2012) A M Devlin et al.   Translational Psychiatry

Atypical Antipsychotic-Induced Weight Gain

(2011) James L. Roerig et al.   CNS DRUGS

Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients

(2011) Daimei Sasayama et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Identification of a biological signature for schizophrenia in serum

(2011) E Schwarz et al.   MOLECULAR PSYCHIATRY

Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?

(2010) M A Febbraio et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Adjunctive Use of Metformin to Treat or Prevent Atypical Antipsychotic-Induced Weight Gain: A Review

(2010) Ahsan Y. Khan et al.   Journal of Psychiatric Practice

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial

(2010) Preeta Kaur Narula et al.   SCHIZOPHRENIA RESEARCH

Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis

(2009) Sahoo Saddichha et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial

(2009) T. Baptista et al.   PHARMACOPSYCHIATRY

Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?

(2009) David B. Allison et al.   PSYCHIATRY RESEARCH

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

(2009) Stephen B. Wheatcroft et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms

(2008) S. Buchholz et al.   INTERNAL MEDICINE JOURNAL

Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course

(2008) Stefan Gebhardt et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Glucose abnormalities in the siblings of people with schizophrenia

(2008) Emilio Fernandez-Egea et al.   SCHIZOPHRENIA RESEARCH